A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders

Pharmacogenomics Journal

Volumn 8, Issue 2, 2008, Pages 101-112

  Gratacos M ^a   Soria, V ^b   Urretavizcaya, M ^b   Gonzalez J R ^a   Crespo, J M ^b   Bayes M ^a   de Cid, R ^a   Menchon J M ^b   Vallejo, J ^b   Estivill, X ^a,c  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MOOD DISORDER; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPAIN; TREATMENT OUTCOME;

EID: 40949152013     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500460     Document Type: Article

References (86)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
2. Thase ME, Rush AJ. When at first you don't succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997; 58(Suppl 13): 23-29.
3. Simpson S, Baldwin RC, Jackson A, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 1998; 28: 1015-1026.
4. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O et al. Treatment resistant depression: Methodological overview and operational criteria. Eur Neuropsychopharmacol 1999; 9: 83-91.
5. Nierenberg AA. Predictors of response to antidepressants general principles and clinical implications. Psychiatr Clin North Am 2003; 26: 345-352, viii.
6. losifescu DV, Clementi-Craven N, Fraguas R, Papakostas GI, Petersen T, Alpert JE et al. Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder. Psychosom Med 2005; 67: 703-706.
7. Lesch KP, Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog Neuropsychopharmacol Bial Psychiatry 2005; 29: 1062-1073.
8. Bondy B. Pharmacogenomics in depression and antidepressants. Dialogues Clin Neurosci 2005; 7: 223-230.
9. Levinson DF. The genetics of depression: A review. Biol Psychiatry 2006; 60: 84-92.
10. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
11. Barde YA. Trophic factors and neuronal survival. Neuron 1989; 2 1525-1534.
12. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989; 341: 149-152.
13. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350: 230-232.
14. Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 1991; 88: 961-965.
15. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survivil and sprouting of serotonergic axons in rat brain. J Neurosci 1995; 15: 7929-7939.
16. Croll SD, Wegand SJ, Anderson KD, Lindsay RM, Nawa H. Regulation of neuropepticles in adult rat forebrain by the neurotrophins BDNF and NGF. Eur J Neurosci 1994; 6: 1343-7353.
17. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM et al. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science 1990; 247: 1446-1451.
18. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 93-103.
19. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
20. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75.
21. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068-1072.
22. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005; 51: 234-238.
23. Gonul AS, Akdeniz F, Taneli F, Donat Q, Eker C, Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005; 255: 381-386.
24. Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261-265.
25. Lommatzsch M, Hornych K, Zingler C, Schuff-Werner P, Hoppner J, Virchow JC. Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology 2006; 31: 388-394.
26. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA et al Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006; 398: 215-219.
27. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579-593.
28. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
29. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook Jr EH. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-1700.
30. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (PDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 139: 51-53.
31. Okada T, Hashimoto R, Numakawa T, Iijima Y, Kosuga A, Tatsumi M et al A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol Psychiatry 2006; 11: 695-703.
32. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17-20.
33. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186-189.
34. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder a Belgian patient-control study. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 34-35.
35. Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T et al No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: A multicenter study. Biol Psychiatry 2004; 56: 376-378.
36. Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, Kosmowska M, Kapelski P et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5 215-220.
37. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P et al BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005; 10: 208-212.
38. Green EK, Raybould R, Macgregor S, Hyde S, Young AH, O'Donovan MC et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: Case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006; 188: 21-25.
39. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 2003; 123: 19-22.
40. Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, Luben R, Day NE et al. No association between the BDNF Val66Met pollymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 2007; 41: 404-409.
41. Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet 2004; 131: 16-19.
42. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB et al Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-314.
43. Strauss J, Barr CL, George CJ, Devlin B, Vetro A, kiss E et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: Confirmation in a Hungarian sample. Mol Psychiatry 2005; 10: 861-867.
44. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006; 27: 1834-1837.
45. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-7547.
46. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000; 101: 305-312.
47. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2003; 23: 349-357.
48. Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 2004; 29: 2189-2199.
49. Rogoz Z, Skuza G, Legutko B. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. J Physiol Pharmacol 2005; 56: 661-671.
50. Rogoz Z, Legutko B. Combined treatment with imipramine and metyrapone induces hippocampal and cortical brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep 2005; 57: 840-844.
51. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251-3261.
52. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137.
53. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007; 61: 187-197.
54. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 2006; 1118: 176-182.
55. Jiang X, Xu K, Haberman J, Tian F, Marko AJ, Waheed JF et al. BDNF variation and mood disorders: A novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005; 30: 1353-1361.
56. Shimizu E, Hashimoto K, Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004; 126 122-123.
57. Chowbay B, Zhou S, Lee EJ. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore. Drug Metab Rev 2005; 37: 327-378.
58. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993; 10: 475-489.
59. Tabuchi A, Sakaya H, Kisukeda T, Fushiki H, Tsuda M. Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem 2002; 277: 35920-35931.
60. Duman RS. Depression: A case of neuronal life and death? Biol Psychiatry 2004; 56: 140-145.
61. Altar CA, Whitehead RE, Chen R, Wortwein G. Madsen TM. Effects of electroconvulsive seizures and antidepressant drugs on brain derived neurotrophic factor protein in rat brain. Biol Psychiatry 2003; 54: 703-709.
62. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Outawa S et al Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-809.
63. Molteni R, Calabrese F, Bedogni F, Tongiorgi E, Fumagalli F, Racagni G et al. Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions. Int J Neuropsychopharmacol 2006; 9: 307-317.
64. Campbell S, Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 2004; 29: 417-426.
65. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15 1768-1777.
66. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001; 49: 391-404.
67. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, N AG et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003; 53: 707-742.
68. Neumeister A, Yuan P, Young TA, Bonne O, Luckenbaugh DA, Charney DS et al. Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry 2005; 162: 805-807.
69. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319-1325.
70. Licinio J, O'Kirwan F, Irizarry K, Merriman B, Thakur S, Jepson R et al. Association, of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry 2004; 9: 1075-1082.
71. First M, Spitzer R, Gibbon M, Williams JSCIfD-IAID-CVS-IWDCAPP. Structured Clinical Interview for DMS-IV Axis I Disorders-Clinician Version (SCID-IV). American Psychiatric Press: Washington, DC, 1997.
72. Association AP. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. The American Psychiatric Association: Washington, DC, 1994.
73. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
74. Holley C, Murrell SA, Mast BT. Psychosocial and vascular risk factors for depression in the elderly. Am J Geriatr Psychiatry 2006; 14 84-90.
75. Thase M, Rush A. Treatment resistant depression. In: Bloom FEKD (ed). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, 1995 pp, 1081-1097.
76. Baldwin R, Jeffries S, Jackson A, Sutcliffe C, Thacker N, Scott M et al. Treatment response in late-onset depression: Relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med 2004; 34: 125-136.
77. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: Acute response and long-term remission rates. J Clin Psychiatry 2005; 66: 1535-1540.
78. Gauderman WJ. Sample size calculations for matched case-control studies of gene-environment interaction. Stat Med 2002; 21: 35-50.
79. QUANTO 1.1. A computer program for power and sample size calculations for genetic-epidemiology studies, http://hydra.usc.edu/gxe [program] 2006.
80. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-120.
81. Sanchez JJ, Phillips C, Borsting C, Balogh K, Bogus M, Fondevila M et al. A multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis 2006; 27: 1713-1724.
82. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945-959.
83. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998; 281: 363-365.
84. SNPassoc. Genetic Association Studies, [program] R package version 0.5-1 version R Foundation for Statistical Computing: Vienna, 2006.
85. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM et al Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 56-65.
86. Efron B, Tibshirani R. An Introduction to the Bootstrap. Chapman & Hall: New York, 1993.